Management of metastatic melanoma with new immunotherapy approaches beyond PD-1/CTLA-4 inhibitors. Devaux A, Baurain JF. Curr Opin Oncol 2022 Jan 25. pii: 00001622-900000000-98953.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Devaux A, Baurain JF. Management of metastatic melanoma with new immunotherapy approaches beyond PD-1/CTLA-4 inhibitors. Curr Opin Oncol 2022 Jan 25. pii: 00001622-900000000-98953.
PMID: 35081051